On January 31, 2017 Kyowa Hakko Kirin Co., Ltd., an R&D-based life sciences company with special strengths in biotechnology, reported financial results for the fiscal year ended December 31, 2016 (Report, Kyowa Hakko Kirin, JAN 31, 2017, View Source [SID1234517603]). Schedule your 30 min Free 1stOncology Demo! Net worldwide sales for the fiscal year ended December 31, 2016 were 343.0 billion yen, a 6% decrease from that of 364.3 billion yen for the fiscal year ended December 31, 2015. Regional Sales for the fiscal year ended December 31, 2016 were as follows: Japan 246.7 bn yen, Americas 17.7 bn yen, Europe 49.1 bn yen, Asia, 28.1 bn yen and other regions amounted to 1.1 bn yen.
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
For Kyowa Hakko Kirin Co., Ltd’s detailed reported for the fiscal year ended December 31, 2016, visit: View Source